News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResApp Health.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
News
Closing Bell: ASX treads water while an IPO dips on debut
Health & Biotech
ASX Health Stocks: Lumos is ready to seek regulatory approval for its COVID-19 rapid antigen test
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
ASX Health: 4D Medical jumps 16pc on lungs device rollout, Proteomics up 10pc on UK deal
News
10 at 10: These ASX stocks are attracting the most intrigue this morning
Health & Biotech
ASX Health Stocks: Mesoblast jumps 10pc on Phase 3 trial results for chronic heart failure
Health & Biotech
ASX Health Stocks: Resapp gains on India COVID-19 trial, Atomo to supply HIV self-test in Australia
Health & Biotech
Check Up: ASX biotech comes alive as health stocks tackle international markets
Health & Biotech
ASX Health Stocks: Cannabis play Cronos scoots 19% higher on merger news, Telix gets FDA nod for clinical trial
Health & Biotech
ScoPo’s Powerplays: Smaller capped health stocks are still in ‘no man’s land’, but Neuren jumps 18pc this week
News
Closing Bell: ASX closes Wednesday 0.38% higher but short of all time high
News
ASX Small Cap Lunch Wrap: Who’s crunching the numbers today?
Health & Biotech
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare
News
Trading Places: Which fund manager took a $10.5m+ punt on salmon stock Tassal?
News
ASX Small Cap Lunch Wrap: Health tech companies lead the way; oil royalties and media firms lag
Health & Biotech